UBS raises GitLab stock price target to $35 on improved demand outlook

UBS raised its GitLab (GTLB) price target to $35 from $32 while keeping a Neutral rating, citing improved near-term demand signals from an investor lunch. The stock trades around $33.55 near fair value as management highlighted “very healthy” seat growth, while UBS still views DAP as a mostly fiscal 2028+ driver and waits for confirmation on seat stabilization and DAP traction. The note follows GitLab’s solid Q1 revenue growth of 23.1% (+3.6% vs expectations), with additional analyst target hikes from DA Davidson (to $35) on Duo Agent Platform impact.

Analysis

The near-term setup is more about sentiment repair than a fundamental rerate: GTLB looks like a name where downside is increasingly tied to execution proof, not liquidity stress. With gross margins already high and the balance sheet clean, incremental confidence in seat growth should flow disproportionately into FCF assumptions, but the market will not pay up for DAP until it sees repeatable conversion rather than pilot language.

Competitively, the key winner from a stabilization thesis is not the platform itself but the ecosystem around enterprise DevOps spend: if GitLab’s seat counts hold, it validates that budget scrutiny is not forcing a wholesale move to cheaper or bundled alternatives. That would be mildly negative for point solutions and for any vendor relying on displacement to sustain growth, but the larger second-order effect is on software multiple dispersion — profitable, net-cash names with visible growth regain relative appeal versus lower-quality SaaS.

The contrarian miss is that consensus may be too focused on the conservative guide already baked into estimates and not enough on timing risk: DAP is a FY28 story, so even a genuine product win may not change the stock until 1-2 quarters of seat and renewal data confirm it. Over the next few weeks, the stock can drift higher on analyst upgrades, but the real falsifier is another quarter where seat growth or net retention re-accelerates less than expected; that would cap the multiple despite the clean balance sheet. If management does not show measurable conversion from pilot to broader deployment by the next two reporting cycles, the current valuation likely becomes the ceiling rather than the floor.

Key Decisions for Investors

• No aggressive directional trade at current levels; GTLB already screens close to fair value, so the better entry is a pullback into the low-30s or below on no change in seat-growth commentary.
• If you want exposure, use a small starter long in GTLB with a 3-6 month horizon, targeting a move toward the mid-to-high 30s only if next quarter confirms seat stabilization; cut the position if management language on seats or billings deteriorates.
• For convexity, buy a modest Jan-2026 GTLB 35/45 call spread: limited premium outlay, upside only if DAP goes from pilot noise to a real revenue bridge over the next 2-3 quarters.
• Pair idea: long GTLB / short a weaker, less profitable SaaS name with similar enterprise budget sensitivity if you want to isolate quality-of-growth vs. valuation multiple compression; the trade should work only if GTLB proves it can convert stable demand into operating leverage.
• Watch-item, not trade: the first measurable DAP conversion in early calendar Q4 and any update on seat growth in the next earnings cycle; if neither improves, treat the stock as range-bound and fade strength.